Cash & equivalents increased 271.0%
Cash & equivalents changed +271.0% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +271.0% from the comparable as-filed period.
Gross margin changed +1513 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Gross profit changed -99.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Net income changed +58.3% from the comparable as-filed period.
Operating income changed +53.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating margin changed -516775 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Research & development changed -80.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Revenue changed -99.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Selling, general & administrative changed -52.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.